GAS1 appeared to have a relatively specific association with risk of triple negative breast cancer [OR: 1.88, 95% CI: 1.42 to 2.47; PP4: 0.86] but was also associated with a lower risk of HER2 enriched breast cancer [OR: 0.46, 95% CI: 0.27 to 0.78; PP4: 0.78]. Here, ERBB2 is linked to triple-negative breast carcinoma.